Research - London, England, United Kingdom
Apta Biosciences has developed a proprietary, groundbreaking method for creating synthetic alternatives to antibodies, a core component of medical diagnostics and therapeutics. The company is a spin-out from Fujitsu, where the technology was originally developed.